German Software Stock News

XTRA:SY1
XTRA:SY1Chemicals

Symrise (XTRA:SY1) Stock Faces Margin Crunch Behind Premium P/E

Symrise stock entered this H1 report with a 90-day gain of about 18.7% and a flat month behind it. This means expectations were quietly reset higher even before the numbers were released. The headline is not revenue in this flavour and fragrance specialist; it is profitability. Trailing net profit margin now sits at 5%, roughly half the 10.2% level reported a year earlier, while the P/E multiple stands at 49.6x versus industry averages near 20x. Short-term optimism now meets a longer-term...
XTRA:SHF
XTRA:SHFIT

SNP Schneider Neureither And Partner (XTRA:SHF) Stock Rises On Profit Surge Yet Forecasts Caution

SNP Schneider-Neureither & Partner stock closed at €81.8 after the Q2 print, barely moved over the past week and still weaker over the last three months. The muted reaction sits against earnings that keep pushing higher net income and earnings per share, with Q2 net profit at €11.026m. The bigger story sits beyond this quarter. Trailing earnings are much stronger than a year ago, yet analyst models point to slightly declining earnings over the next three years even as revenue is forecast to...
XTRA:SHL
XTRA:SHLMedical Equipment

Siemens Healthineers (XTRA:SHL) Lifted Guidance On Third Quarter Results, Is The Discount Still There?

Third quarter earnings and guidance shift put Siemens Healthineers in focus Siemens Healthineers (XTRA:SHL) is back on investors’ radar after third quarter results, a guidance tweak linked to tariff refunds, and fresh value partnerships in the United States. The company reported third quarter sales of €5,764 million and net income of €669 million, with basic earnings per share from continuing operations of €0.60. Imaging and Precision Therapy segments were highlighted alongside ongoing...
XTRA:ACT
XTRA:ACTChemicals

AlzChem Group (XTRA:ACT) Could Be 25% Undervalued As Strong 2026 Earnings Land

AlzChem Group (XTRA:ACT) has drawn fresh attention after reporting second quarter and first half 2026 results, with both sales and net income higher than the same periods a year earlier. See our latest analysis for AlzChem Group. Despite the stronger first half of 2026 results, AlzChem Group’s share price has fallen 11.6% over the past day and is down 12.3% over the past week, although the 5 year total shareholder return of over 6x points to a much stronger longer term picture. If this...
XTRA:R3NK
XTRA:R3NKMachinery

RENK Group (XTRA:R3NK) Refinancing Leaves An Open Question On Valuation

RENK Group (XTRA:R3NK) has completed a major refinancing, replacing its leveraged buyout debt with a €1.05b unsecured syndicated loan package. This change in capital structure is central to the company’s current stock story. See our latest analysis for RENK Group. RENK Group’s refinancing news comes after a mixed price pattern, with the share price up about 13% over the past 30 days but down about 12% over 90 days and the one year total shareholder return down about 29%. The recent short term...
XTRA:BFSA
XTRA:BFSACommercial Services

Befesa (XTRA:BFSA) Stock Can Margin Gains Justify Its 16.2x P/E?

Befesa stock went into this earnings day with a mixed mood. The price is roughly flat over the past week but up about 16% over the past month, which suggests expectations had already crept higher. The headline is simple. Q2 net income of €24.3m and basic earnings per share of €0.61 point to a cleaner margin story that aligns with the recent improvement in trailing net profit margin to 7.3%. The question now is whether that margin strength justifies a P/E of 16.2x when the wider European...
XTRA:AOF
XTRA:AOFSoftware

ATOSS Software (XTRA:AOF) Lifts Guidance, Is It Still Below Fair Value?

ATOSS Software (XTRA:AOF) drew fresh investor attention after releasing second quarter 2026 results along with new guidance for 2026 and 2027, outlining specific revenue targets and minimum EBIT margin levels. See our latest analysis for ATOSS Software. ATOSS Software shares have climbed strongly in the short term, with a 7 day share price return of 23.52% and a 30 day return of 27.95%, although the year to date share price return is down 24.25% and the 1 year total shareholder return is down...
XTRA:DBK
XTRA:DBKCapital Markets

Deutsche Bank (XTRA:DBK) Stock Faces Profit Squeeze Despite Revenue Growth

Deutsche Bank stock closed at €31.86 with solid recent momentum, up about 6% over seven days and 20% over three months. The headline in the earnings, however, sits on the income statement. Q2 net income came in at €1,102m with basic earnings per share of €0.58, well below Q1 levels, which puts the current quarter’s profit squeeze in sharp focus. For traders focused on the quarter-on-quarter step down, that gap is the story. For long-term investors, the real question is how that margin...
XTRA:ADS
XTRA:ADSLuxury

adidas (XTRA:ADS) Could Be 22% Undervalued As Record Q2 Sales Lift Outlook

adidas (XTRA:ADS) is back in focus after reporting record second quarter 2026 net sales and lifting its full year growth outlook, with strong contributions from Latin America, Japan, South Korea and North America. See our latest analysis for adidas. Despite adidas raising its full year growth outlook after record Q2 sales, the stock has recently come under pressure. The 1 day share price return has fallen 11.52% and the 30 day share price return is down 10.12%. That follows a stronger 90 day...
XTRA:WSU
XTRA:WSUMachinery

3 Undiscovered European Gems With Strong Potential

As the pan-European STOXX Europe 600 Index recently edged up, reflecting robust corporate earnings amidst geopolitical tensions and fluctuating oil prices, investors are increasingly attentive to small-cap opportunities that may offer substantial growth potential. In this dynamic environment, identifying stocks with strong fundamentals and resilience can be particularly rewarding, especially when they operate in sectors poised for expansion despite broader market challenges.
XTRA:SRT3
XTRA:SRT3Life Sciences

What Sartorius (XTRA:SRT3)'s Stronger Profit Growth Than Sales Means For Shareholders

Sartorius Aktiengesellschaft recently reported past results for the second quarter and first half of 2026, with second-quarter sales of €911.8 million and net income of €65.9 million, alongside six-month sales of €1.81 billion and net income of €122.2 million, all higher than the prior year’s levels. The sharper increase in net income than in sales suggests improved operational efficiency and cost management within Sartorius’s business over the period. We’ll now examine how this improved...
XTRA:LHA
XTRA:LHAAirlines

Deutsche Lufthansa (XTRA:LHA) Rebounds After A Sharp Drop, Is The Stock Fully Valued?

Deutsche Lufthansa (XTRA:LHA) is back in focus after recent share price swings, with the stock up 1.7% over the past day but down about 9.6% over the past month. See our latest analysis for Deutsche Lufthansa. For context, Deutsche Lufthansa’s share price return has gained 7% over the past week but is still down about 9.6% over the past month, while the 1 year total shareholder return stands at 24.8%, suggesting momentum has been rebuilding over the medium term. If these moves have you...
XTRA:BMW
XTRA:BMWAuto

Bayerische Motoren Werke (XTRA:BMW) Could Be 67% Below Fair Value As Earnings Slip

Bayerische Motoren Werke (XTRA:BMW) is back in focus after announcing a voluntary redundancy programme in Germany, alongside quarterly results that showed lower sales and net income compared with the same periods in 2025. See our latest analysis for Bayerische Motoren Werke. At a share price of €60.18, Bayerische Motoren Werke has seen short term momentum pick up, with a 7 day share price return of 5.73% and 30 day return of 5.10%. However, the year to date share price return is still down...
XTRA:TMV
XTRA:TMVSoftware

Why TeamViewer (XTRA:TMV) Is Up 10.1% After Strong H1 Earnings And ServiceNow Partnership Announcement

In late July 2026, TeamViewer SE reported half-year 2026 results showing sales of €365.92 million and net income of €64.29 million, with basic and diluted earnings per share from continuing operations of €0.41 versus €0.33 a year earlier. The company also highlighted an adjusted EBITDA margin of 43.2%, growing enterprise demand for its TeamViewer One platform, and a new partnership with ServiceNow alongside FedRAMP in progress status to access the US federal market. Next, we’ll examine how...
XTRA:ALV
XTRA:ALVInsurance

Can Allianz (XTRA:ALV) Justify Its Valuation After The HSBC Singapore Deal?

Allianz (XTRA:ALV) is back in focus after agreeing to buy HSBC’s Singapore life and health insurance unit for $2.09b, along with a 15-year exclusive bancassurance partnership across the city-state. See our latest analysis for Allianz. The HSBC Singapore deal comes at a time when Allianz’s momentum is already positive, with a 30-day share price return of 4.11% and a 90-day share price return of 10.82%, alongside a 5-year total shareholder return of 185.20%. If this kind of corporate activity...
XTRA:P911
XTRA:P911Auto

Porsche (XTRA:P911) Stock Can Premium Pricing Offset A Deep Margin Squeeze?

Porsche stock came into this earnings day having edged down about 3% over the past week, yet it still carries a rich trailing P/E of 47.4x that prices in a lot of faith. The headline from this quarter is simple: profit quality is under pressure while the valuation remains demanding. Q2 2026 net income of €737m sits inside a 12 month story where net margin is just 2.4% compared with 5.6% a year earlier and the dividend is not well covered by earnings or free cash flow. The market reaction now...
XTRA:BAS
XTRA:BASChemicals

BASF (XTRA:BAS) Stock Gains A Profit Jolt While Cash Remains Elusive

BASF stock came into this earnings day with a solid rebound behind it, up about 9.5% over the past month. However, the real story is what sits under the hood. The market is reacting to a chemicals giant that just reported a very sharp swing in profitability, helped by a €3.5b after tax gain from the Coatings sale. The emotional tug of war is clear. Bulls are focusing on a 54% jump in Q2 EBITDA before special items to €2.4b and a higher full year EBITDA target. Skeptics are watching negative...
XTRA:RDC
XTRA:RDCConsumer Retailing

Redcare Pharmacy (XTRA:RDC) Stock Can Early Profit Ease Margin Doubts?

Redcare Pharmacy stock came into this earnings print on the back of a strong 90 day run, yet the latest move now hinges on a single question: Is the market reacting to genuine profit traction or just momentum fatigue? The headline is simple. The online pharmacy group pushed quarterly revenue to €853.5m and swung from a loss in Q1 to a modest €4.7m profit with positive earnings per share. The real story for investors is whether this early return to profitability justifies the recent rally or...
XTRA:MUB
XTRA:MUBMachinery

Mühlbauer Holding (XTRA:MUB) Stock Price Lags A Sharp Margin Recovery

Mühlbauer Holding went into this earnings season with a value label and a share price that has barely moved over the past month, yet the latest numbers tell a more forceful story. The stock closed at €39.6 on 30 July while the trailing twelve month net profit margin now sits at 6.6%, up from 2.6% a year earlier, and earnings have risen sharply over that period. The headline today is clear: profitability in this machinery specialist has recovered far faster than the share price suggests. If...
XTRA:TGHN
XTRA:TGHNLogistics

Logwin (XTRA:TGHN) Stock Price Stalls As Margins And EPS Retreat

Logwin’s share price closed flat at €284 after the half year 2026 release, which indicates the market has not made up its mind. Yet the core earnings story points to pressure. Net profit margins over the last year sit at 4%, slightly below the prior 4.2%, while earnings per share on a trailing twelve month basis are lower than in recent periods. Investors are treating the stock as fairly valued for now, even though the earnings trend looks softer and forecasts point to further declines. The...
XTRA:NDX1
XTRA:NDX1Electrical

Nordex (XTRA:NDX1) Stock Price Hinges On Whether 10.3% Margins Hold

Nordex stock went into this earnings day under pressure, down about 14% over the past month and about 18% over the past quarter, with investors clearly braced for disappointment. Instead, the company delivered a clean headline that goes straight to profitability. Second quarter 2026 revenue reached €2.18b with net profit of €111.5m and an EBITDA margin a touch above 10%, which is high for onshore wind equipment. The real story is margin repair, not just revenue size, and that is what will...
XTRA:BFSA
XTRA:BFSACommercial Services

Befesa (XTRA:BFSA) Could Be 15% Undervalued Following Reaffirmed Guidance And Bernburg Plans

Befesa (XTRA:BFSA) is back in focus after reporting second quarter and half year 2026 results, with adjusted EBITDA at €124 million and management reaffirming full year guidance while detailing its Bernburg expansion plans. See our latest analysis for Befesa. Befesa’s recent earnings update and Bernburg expansion have come as the share price has risen 16.08% over the past month and delivered a 35.20% 1 year total shareholder return, although the 5 year total shareholder return is still down...